Brandi Roberts - Oct 25, 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CFO
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Oct 25, 2024
Transactions value $
$0
Form type
4
Date filed
10/29/2024, 04:40 PM
Previous filing
Jul 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Retention Restricted Stock Units Award $0 +7.9K $0.00 7.9K Oct 25, 2024 Voting Common Stock 7.9K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The retention restricted stock units ("Retention RSUs") vest in full on the earlier of October 25, 2025, or the date of the Reporting Person's Involuntary Termination (as defined in the Reporting Person's employment agreement) (such earlier date, the "Vesting Date"). The shares underlying the Retention RSUs will be issued upon vesting and release of the Retention RSUs. If the acquisition of the Issuer pursuant to the Agreement and Plan of Merger attached as Exhibit 2.1 to the Issuer's Current Report on Form 8-K filed with the SEC on October 15, 2024 (the "Merger Agreement") is completed prior to the Vesting Date, then, as of and following the Effective Time (as defined in the Merger Agreement), the Retention RSUs shall be settled via payment of an amount in cash, without interest, equal to the product of the Merger Consideration (as defined in the Merger Agreement) multiplied by the number of Retention RSUs, with such amount payable to the Reporting Person on the Vesting Date.